Who are Comparator: Varicella Zoster Virus Vaccine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): varicella zoster virus, Shingrix, VI, Pentavalent rotavirus vaccine, varicella-3, Bacillus Calmette-Guerin (BCG).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/comparator-varicella-zoster-virus-vaccine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Comparator: Varicella Zoster Virus Vaccine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparator: Varicella Zoster Virus Vaccine (Comparator: Varicella Zoster Virus Vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

phase 3 Live attenuated vaccine Varicella zoster virus Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Comparator: Varicella Zoster Virus Vaccine (Comparator: Varicella Zoster Virus Vaccine) — Merck Sharp & Dohme LLC. This vaccine stimulates the immune system to produce antibodies and cellular immunity against varicella zoster virus, preventing chickenpox and herpes zoster infection.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Comparator: Varicella Zoster Virus Vaccine TARGET	Comparator: Varicella Zoster Virus Vaccine	Merck Sharp & Dohme LLC	phase 3	Live attenuated vaccine	Varicella zoster virus
varicella zoster virus	varicella zoster virus	AstraZeneca	marketed	Live attenuated viral vaccine	Varicella zoster virus envelope glycoproteins
Shingrix	shingrix	GSK	marketed	Vaccine	Varicella zoster virus
VI	VI	GlaxoSmithKline	marketed	Recombinant zoster vaccine	Varicella zoster virus glycoprotein E (gE)
Pentavalent rotavirus vaccine	Pentavalent rotavirus vaccine	Sanofi Pasteur, a Sanofi Company	marketed	Live attenuated vaccine
varicella-3	varicella-3	Beijing Center for Disease Control and Prevention	marketed	Live attenuated vaccine	Varicella-zoster virus
Bacillus Calmette-Guerin (BCG)	Bacillus Calmette-Guerin (BCG)	Massachusetts General Hospital	marketed	Live attenuated vaccine / Immunotherapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Comparator: Varicella Zoster Virus Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/comparator-varicella-zoster-virus-vaccine. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab